Clinical Trial

Predicting Esophageal Cancer Borders Using PET-Imaging

Study acronym: PEGASUS
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study examines the diagnostic precision of endosonography, mpMRI and PET/CT in defining tumor boundaries and tumor spread before and after neoadjuvant therapy and definitive surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-07.
Trial Details
NCT Number NCT06408116
Lead Sponsor University Hospital Heidelberg
Conditions Esophagus Cancer, Stage I, Esophagus Cancer, Stage II
Enrollment 30 participants
Start Date 2024-03-01
Primary Completion 2028-01 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-10